ow-dose Prednisolone for Prevention of Recurrences in Adult Immune Thrombocytopenia (ITP)

Phase 2

Recruiting

• Conditions: Immune thrombocytopenia (ITP); Prednisolone; Low dose; Recurrence

• Registration Number: TCTR20140213002
• Lead Sponsor: Faculty of Medicine, Chulalongkorn University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-02-13
• Study Completion: 2015-02-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 76

Inclusion Criteria

ITP patients who have been treated and responsive to steroids
Age over 15 years
Current platelet count of 30000/uL or over

Exclusion Criteria

Secondary ITP
Prednisolone dose 7.5 mg/d or below more than 3 months
Refractory ITP
Post-splenectomy
Contra-indication to steroids

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ITP recurrence 10-month follow-up Platelet count

Secondary Outcome Measures

Name	Time	Method
Platelet count 10-month follow-up Platelet count